Immuron Limited Share Price
NASDAQ: IMRN$0.92
+$0.92 (--%) Last updated on 29 Oct, 2026 | 01:04 ISTImmuron Limited Stock Performance
Immuron Limited Share Price Chart
$0.92$0.92
L
H
About Immuron Limited
Immuron Ltd is a commercial- and clinical-stage biopharmaceutical company focused on the development and commercialization of specifically targeted polyclonal antibodies. Its oral polyclonal antibodies offer delivery within the GI tract and can target viruses or bacteria and neutralize toxins at mucosal surfaces. The Company markets Travelan in Australia, an over-the-counter orally administered passive immunotherapeutic product indicated to reduce the risk of traveler's diarrhea and minor gastrointestinal disorders. Its products include Travelan, ProIBS and Protectyn. Its segments are Research and Development and Hyper-immune products, with Hyper-immune products generating maximum revenue. Australia generates maximum revenue.
Immuron Limited Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $1.15 | $0.92 | -20.95% |
Sep 2026 | $1.09 | $1.16 | +3.57% |
Aug 2026 | $1.06 | $1.12 | +0.90% |
Jul 2026 | $1.07 | $1.11 | +4.72% |
Jun 2026 | $1.57 | $1.06 | -26.64% |
May 2026 | $0.79 | $1.45 | +70.20% |
Apr 2026 | $0.79 | $0.85 | +4.94% |
Mar 2026 | $0.80 | $0.81 | -4.71% |
Feb 2026 | $0.89 | $0.85 | -6.19% |
Jan 2026 | $0.80 | $0.91 | +17.84% |
Dec 2025 | $1.67 | $0.77 | -54.96% |
Nov 2025 | $1.95 | $1.71 | -10.73% |